Latest Liver biopsy Stories
Introducing FibroScan®: A New FDA-registered Medical Device to measure Liver Fibrosis.
Argon Medical Expands its Comprehensive Biopsy Portfolio with the Addition of the TLAB® Transjugular Liver Biopsy Instrument PLANO, Texas, Sept.
LONDON, July 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Technique Allows for Non-Invasive Liver Analysis and Improved Patient Outcomes East Providence, RI (PRWEB) December 18, 2013 Rhode Island Medical Imaging
Breast biopsies can adversely affect short-term quality-of-life, and the effects are more pronounced in younger patients.
A new, non-invasive imaging technique, magnetic resonance elastography (MRE), can now help physicians accurately detect fibrosis (scarring) in children with chronic liver disease – a growing problem due in part to increasing obesity rates.
New research reveals that advanced fibrosis is a significant predictor of mortality in patients with nonalcoholic fatty liver disease (NAFLD), largely brought about by cardiovascular causes.
The discovery of a mummified Korean child with relatively preserved organs enabled an Israeli-South Korean scientific team to conduct a genetic analysis on a liver biopsy which revealed a unique hepatitis B virus (HBV) genotype C2 sequence common in Southeast Asia.
EASL today announced the publication of a new clinical practice guideline (CPG) in the area of Alcoholic Liver Disease (ALD), bringing the number of CPGs published to date to eight.